Shaping wound care policy across Europe
We are proud to play our part in shaping the future of wound care in Europe. Mölnlycke has been elected one of the organisations leading the Wound Care Sector Working Group at MedTech Europe, the industry association representing medical technology across the continent.
This leadership role reflects Mölnlycke’s commitment to driving meaningful change in wound care policy.
The MedTech Europe Wound Care Sector Working Group has a clear goal: raise awareness and drive systemic improvements in chronic wound care across healthcare systems in Europe. Chronic wounds represent a significant and often underestimated challenge, impacting millions of lives and placing a heavy strain on resources.
By engaging policymakers across the European Union and in multiple countries, the working group seeks to raise awareness of the challenges in wound care and establish chronic wounds as a recognised health priority. Through coordinated action, the group aims to drive systemic improvements by aligning healthcare systems, promoting transparency in resource allocation, and supporting education for healthcare professionals and patients. This industry-wide collaboration brings together leading stakeholders with a shared commitment to ensuring timely, appropriate and high-quality wound care that improves patient outcomes and supports sustainable healthcare.
Isabella Notarangelo, Mölnlycke’s Global Governmental Affairs and Policy Manager, has been elected Co-Vice-Chair of the Wound Care Sector Working Group.
By partnering with leading companies and national associations through MedTech Europe, Mölnlycke is proud to help shape a future where wounds are not only treated, but wherever possible, prevented and effectively managed.
Latest news
-
New leaders appointed for Mölnlycke Health Care
Gothenburg, Sweden. 3 November 2026. Mölnlycke® announces the appointment of Anders Andersson as Chief Executive Officer (CEO) of Mölnlycke Health Care and Fredrik Wallefors as President of Surgical, effective 1 January 2027.
-
Mölnlycke Health Care announces new partnership with DEBRA International to help advance wound care for the EB community
Mölnlycke is partnering with DEBRA International, the world’s leading epidermolysis bullosa (EB) patient advocacy network, to deepen understanding of the needs of people living with EB and help advance wound care for the global EB community.
-
Mölnlycke and AROA partner to expand access to Endoform in the US
Mölnlycke Health Care has entered an exclusive agreement with AROATM to co-promote EndoformTM in the United States in post-acute settings, effective 16 October 2026.
-
Martin Ma joins Mölnlycke Zhende as General Manager
In this role, Martin will lead the joint venture's operations and growth strategy in China, with responsibility for commercial execution, organisational leadership, governance and delivery of growth ambitions in one of the world's largest wound care markets.
-
Mölnlycke launches MyFit™ by Biogel® to bring more inclusive sizing to surgical gloves
-
Mölnlycke joins ALPS as Gold Strategic Partner to advance limb preservation
Mölnlycke has joined the American Limb Preservation Society (ALPS) as an official Gold Strategic Partner, reinforcing a shared commitment to improving outcomes for patients at risk of amputation due to diabetic foot complications.
-
New consensus document highlights need to address post-operative blistering to improve patient outcomes
At Mölnlycke Health Care, we work alongside clinicians, researchers and healthcare experts to advance evidence-based care and help raise standards for post-operative care.
-
From pressure to potential: new report reveals opportunity to increase healthcare capacity
Gothenburg, Sweden. 21 September 2026. Mölnlycke Health Care (Mölnlycke®), a global leader in MedTech, today announces the launch of The Hidden Capacity Report, a new international report revealing significant opportunities to expand day surgery and help healthcare systems improve efficiency, increase surgical throughput and enhance patient outcomes.
-
Mölnlycke to separate its surgical solutions business into a standalone company
Gothenburg, Sweden. 16 September 2026. Mölnlycke®, a global leader in MedTech, announces its intention to separate its Operating Room Solutions (ORS) and Gloves businesses into a new standalone company (referred to here as “Mölnlycke Surgical”). The separation is intended to create conditions for both Mölnlycke and Mölnlycke Surgical to reach their full potential and drive value creation long-term.